Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-11-2022 | Femoral Fracture | Case report

Bisphosphonates/denosumab/ibandronic-acid

Atypical femoral fractures: 3 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Everts-Graber J, et al. ATYPICAL FEMORAL FRACTURES IN PATIENTS WITH OSTEOPOROSIS TREATED WITH DENOSUMAB OR BISPHOSPHONATES. Aging Clinical and Experimental Research 34 (Suppl. 1): S316-S317 abstr. P641, Sep 2022. Available from: URL: http://doi.org/10.1007/s40520-022-02147-3 [abstract] Everts-Graber J, et al. ATYPICAL FEMORAL FRACTURES IN PATIENTS WITH OSTEOPOROSIS TREATED WITH DENOSUMAB OR BISPHOSPHONATES. Aging Clinical and Experimental Research 34 (Suppl. 1): S316-S317 abstr. P641, Sep 2022. Available from: URL: http://​doi.​org/​10.​1007/​s40520-022-02147-3 [abstract]
Metadata
Title
Bisphosphonates/denosumab/ibandronic-acid
Atypical femoral fractures: 3 case reports
Publication date
01-11-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-26939-9

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Lamivudine

Case report

Antineoplastics